First pictures of enzyme that drives new class of antibiotics
Researchers from Arts & Sciences have solved the X-ray crystal structure of the enzyme that makes obafluorin — a broad spectrum antibiotic agent made by a fluorescent strain of soil bacteria. This new class of antibiotics might provide a powerful antidote to the growing scourge of antibiotic resistance.
Takes a licking and keeps on storing
Researchers in Arts & Sciences made an energy storage device that can withstand a hammer striking it more than 40 times. The shatterproof supercapacitor is also nonflammable, unlike lithium-ion batteries. The new work is the cover story of the April 23 issue of the journal Sustainable Energy and Fuels.
The global helium shortage hits home
Helium is a valuable, non-renewable resource that is critical for many medical and research applications. But helium supply and pricing are unreliable. Sophia Hayes, a professor of chemistry in Arts & Sciences, spoke at a recent American Chemical Society webinar about the need for congressional action to address these challenges.
Of research and results
James McCarter, MD/PhD ’98, whose entrepreneurial spirit was nurtured while a grad student, has built his career on translational research.
Specialist enzymes make E. coli antibiotic resistant at low pH
New research from Arts & Sciences suggests that many “redundant” enzymes are actually specialists that ensure maximal growth across different environments. They also seem to increase resistance to antibiotics in conditions like those in the GI tract or urinary tract — raising concerns that current antibiotic susceptibility tests are inadequate.
‘Featherweight oxygen’ discovery opens window on nuclear symmetry
Researchers in Arts & Sciences have discovered and characterized a new form of oxygen dubbed “featherweight oxygen” — the lightest-ever version of the familiar chemical element oxygen, with only three neutrons to its eight protons.
Engineering proteins to help counter devastating diseases
Meredith Jackrel, assistant professor of chemistry in Arts & Sciences, recently received a five-year grant from the National Institutes of Health (NIH) and another from the Longer Life Foundation to study protein disaggregases — evolved protein forms that mitigate protein misfolding — as a strategy to combat neurodegenerative diseases such as Alzheimer’s, Parkinson’s and ALS.
Better together: Mitochondrial fusion supports cell division
New research from Gary Patti’s laboratory in Arts & Sciences shows that when cells divide rapidly, their mitochondria are fused together. In this configuration, the cell is able to more efficiently use oxygen for energy. This work illuminates the inner workings of dividing cells and shows how mitochondria combine to help cells to multiply in unexpected ways.
Engines through the ages: Nobel laureate to deliver Weissman Lecture
2016 Nobel laureate Fraser Stoddart will deliver the Weissman Lecture Oct. 4 at Washington University in St. Louis. The lecture journeys into mechanical innovations realized during the early and mid-20th century and a new type of bonding in molecules consisting of mechanical linkages. It is free and open to the public.
Barnes named Packard Fellow
Jonathan Barnes, assistant professor of chemistry in Arts & Sciences at Washington University in St. Louis, was among 18 leading young researchers across the United States honored Oct. 16 as a 2017 Packard Fellow.
Older Stories